In addition, subjects with T2D had mildly lower HbA1c values (an absolute difference of −0.14%, 95% CI 0.06–0.23), needed to start insulin 29% less time than controls, and trended towards needing less oral hypoglycemic therapy [78]. The gene discussed is INS; the disease is type 2 diabetes mellitus.